NWI Business Quarterly

IVDiagnostics is one of the featured Companies in Northwest Indiana in their upcoming issue on Life Science companies.

IN Companies to Watch

IVDiagnostics nominated as one of Indiana’s Top 50 Companies to Watch. Companies to Watch (CTW) is a unique awards program developed by the Edward Lowe Foundation to honor second-stage companies that demonstrate high performance in the marketplace, exhibit innovative products or processes, or otherwise make those companies "worth watching."

Molecular Med Tri-Conference

Feb. 19-23 in San Francisco. Dr. Hui Chen, Research Scientist at IVDiagnostics will be presenting a 'Novel Companion Diagnostic for Pancreatic Cancer involving Circulating Tumor Cell Detection and Profiling' on Feb. 20th at the Partnering Forum.

Chicago Arch Angels

February 23 at the Law offices of Michael Best,
 Frank Szczepanski, President and CEO, will be presenting an update
 on IVDiagnostics' novel IVDx platform to interested investors.

Washington DC Arch Angels

February 2 at the Law offices of Wilson,
 Sansoni, Frank Szczepanski presented an overview on IVDiagnostics
 and its platform for monitoring CTCs (circulating tumor cells).

2011

NJ Angels

New Brunswick, NJ, December 15 at the NJ CCIT center, IVDiagnostics
presented to the NJ Angels.

Keiretsu Forum,
 Mid-Atlantic Chapter

Bethesda, MD - December 14 at the Accounting offices of the Reznick Group, Frank Szczepanski presented an IVDiagnostics update to the Keiretsu Forum
 Mid-Atlantic chapter.

Keiretsu Forum

Philidelphia, PA - December 13 at the Law offices of Blank Rome, Frank
Szczepanski presented an update on IVDiagnostics to the Keiretsu Forum
members.

NWI SBDC eDay Event

Merrillville, IN - November 17, IVDiagnostics was named 'Revolutionary
Technology Company of the Year' by the NWI SBDC at the eDay event.

Southern California Bio Conference

Los Angeles, CA - November 9, Frank Szczepanski presented at the 
So. California Bio conference.

Speaker
on WLVP 98.3FM

Valparaiso, IN - November 8, IVDiagnostics' CEO was a guest speaker
on WLVP 98.3FM on the topic of cancer.

Nano-Biotech
Symposium

New York, NY - October 27, IVDiagnostics' CEO attended the Nano-Biotech
symposium hosted by Livingston Securities

Keiretsu Forum

Philadelphia, PA - October 26, IVDiagnostics presented at the Keiretsu
Forum group

Indiana Health Forum

October 25/26, IVDiagnostics attended this industry
Forum in Indianapolis, IN

Chanute award

Hammond, IN - October 20, IVDiagnostics received the Chanute award
from the NWI Society of Innovators.

Tri-Rotary Club

September 27, IVDiagnostics presented to this Rotary
chapter in Munster, IN

Michigan City Rotary Club

September 15, IVDiagnostics presented an update to 
the Michigan City Rotary Club.

NIH – Special Session

"Cancer Detection and Diagnostics Technologies for Global Health" to be held on August 22-23, 2011 on the National Institutes of Health campus in Bethesda, Maryland.

New York Venture Summit

50 of the hottest early stage and emerging growth Technology, Life Sciences and Clean-tech innovators. On July 21, 2011 in New York City, IVDiagnostics, CEO Frank Szczepanski, presented at this Technology event.

2011 World Future Conference

IVDiagnostics, CEO, Frank Szczepanski, presented as one of the 15 finalists for the Futurist Beta Launch. The top 15 finalists illustrated their cutting edge technology in front of 1,000 attendees. The conference was held at the Wall Center in Vancouver, Canada on July 8th-9th 2011. For more details: http://wfsbetalaunch.com. To join go to: www.wfs.org

Molecular Tri-Conference

IVDiagnostics presented at the Molecular Tri-Con Conference that was held in San Francisco on February 23-25, 2011. Topics included: Personalized Diagnostics, Cancer Biologics, Circulating Tumor Cells, and Molecular Diagnostics. Frank Szczepanski, CEO, and Bin Hong, Supervisor of Assay Development presented at the poster board session. The presentation was on: Preclinical Trial for Circulating Tumor Cells Enumeration in Metastatic Breast Cancer Patients using IVDiagnostics OncoIVDx Assay Kit. For more details: Molecular Tri-Conference

Purdue 5K Challenge

IVDiagnostics once again co-sponsored for the 5K Walk/Run Challenge. The Purdue Cancer Center has the stated goals: of preventing cancer; to ease its deletion, and to cure it.. IVDiagnostics fully supports those goals. We had many family and friends join us as they have in the past To continue to support this great cause go to: Purdue 5K Challenge

ASCO Annual Meeting

This year's meeting was held at McCormick Place on June 3-7, 2011, in Chicago, IL. The ASCO Annual Meeting is the premier event in the oncology community, and other educational events provide focused learning in a more interactive environment. The research and education presented at ASCO meetings enhance oncologists’ knowledge, thereby advancing high-quality cancer care. IVDiagnostics attended this event. For further details: ASCO Annual Meeting

2010

MIDAMERICA HEALTHCARE VENTURE FORUM

This event held on November 11, 2010, was attended by our CEO, Frank Szczepanski, which brought together leading Midwest and coastal investors together with corporate business development representatives to syndicate deal flow and facilitate investment opportunities in promising Midwest-based healthcare start-ups. For more details: MIDAMERICA HEALTHCARE VENTURE FORUM

Wisconsin Early Stage Symposium

The 2010 Early Stage Symposium held on November 10-11, 2010, was open to early stage companies representing an array of industries: biotechnology, biofuels and products, “cleantech", advanced manufacturing, information technology, nanotechnology, and business services. IVDiagnostics was represented by Mark Huber, Director of Channel Distribution. For further information, go to: Wisconsin Early Stage Symposium

Indiana Life Sciences Conference

BioCrossroads who worked with Credit Suisse on the 2010 Indiana Life Sciences Summit was held on Oct. 26 and 27. Life science leaders, CEOs, entrepreneurs, venture capitalists, technology transfer officers, and other investors from Indiana and around the U.S. attended this event. Panel sessions and keynotes covered important issues in the biotechnology, medical device and equipment, and funding arenas. Attending this event form IVDiagnostics was Tom Szczepanski, Director of Marketing and Support. For more details: Indiana Life Sciences Conference

Making Strides For Breast Cancer

IVDiagnostics was the flagship sponsor at the Valparaiso, Porter County, IN, Breast Cancer Walk organized by the American Cancer Society. More than just a walk, the Making Strides Against Breast Cancer event describes the progress we’re making together to save lives by helping people get well, stay well, find cures, and fight back. For more information, go to: Making Strides For Breast Cancer

The Burrill Pan-Asia Life Sciences Meeting

The Burrill Pan-Asia Life Sciences Meeting brought together government and industry leaders from China, India, South Korea, Malaysia, Singapore, Taiwan, Australia, and New Zealand for a three-hour meeting to discuss government incentives aimed at making these countries attractive to life sciences companies. Held in early May of 2010, IVDiagnostics was represented by Frank Szczepanski, Mark Huber, and Tom Szczepanski. For More Information: The Burrill Pan-Asia Life Sciences Meeting

MedTech IN3 West 2010 Conference

IVDiagnostics CEO Frank Szczepanski, presented at the IN3 West conference held at the Venetian Resort Hotel, Las Vegas on March 3-5. This event brought together early- to late-stage medical technology companies, investors, and venture capitalists. For more details, go to: MedTech IN3 West 2010 Conference